What is considered a “national application” and “nonprovisional application” in the context of international design applications?

In the context of international design applications, the terms “national application” and “nonprovisional application” have specific definitions according to USPTO rules: National Application: As per 37 CFR 1.9(a)(1), this includes an international design application filed under the Hague Agreement where the USPTO has received a copy of the international registration pursuant to Hague Agreement Article…

Read More

How does representation work when an international design application becomes a national application?

When an international design application transitions to a national application, the rules for representation change. The MPEP provides clear guidance on this matter: For purposes of representation before the Office during prosecution of an international design application that became a national application (see 37 CFR 1.9(a)(1)), the regulations governing national applications shall apply. See 37…

Read More

What is a “bypass” application in the context of PCT applications?

A “bypass” application refers to the filing of a continuation, divisional, or continuation-in-part application of a PCT application designating the United States. This is based on the provisions of U.S. patent law, specifically 35 U.S.C. 363 and 35 U.S.C. 365(c). As stated in the MPEP, “The filing of a continuation, divisional, or continuation-in-part application of…

Read More

How does unity of invention practice differ between national applications under 35 U.S.C. 111(a) and national stage applications under 35 U.S.C. 371?

The unity of invention practice differs as follows: For national applications under 35 U.S.C. 111(a): These are subject to U.S. restriction practice under 37 CFR 1.141-1.146. For national stage applications under 35 U.S.C. 371: These are subject to unity of invention practice under 37 CFR 1.475 and 1.499. MPEP 1896 states: “U.S. national applications filed…

Read More

What are the priority claim requirements for a national application under 35 U.S.C. 111(a) versus a national stage application under 35 U.S.C. 371?

The priority claim requirements differ as follows: For a national application under 35 U.S.C. 111(a): The claim for priority must be filed within the later of four months from the actual filing date or sixteen months from the prior foreign application filing date, as per 37 CFR 1.55(d). For a national stage application under 35…

Read More

What effect does a PCT application designating the US have on filing subsequent US applications?

A PCT application designating the United States has significant effects on filing subsequent U.S. applications. According to 35 U.S.C. 363, “An international application designating the United States shall have the effect, from its international filing date under article 11 of the treaty, of a national application for patent regularly filed in the Patent and Trademark…

Read More

What are the differences in filing fees between national applications under 35 U.S.C. 111(a) and national stage applications under 35 U.S.C. 371?

The filing fees differ as follows: For national applications under 35 U.S.C. 111(a): These are subject to the national application filing fees set forth in 37 CFR 1.16. For national stage applications under 35 U.S.C. 371: These are subject to the national stage fees prescribed in 37 CFR 1.492. MPEP 1896 states: “U.S. national applications…

Read More

How is the filing date determined for a national application under 35 U.S.C. 111(a) compared to a national stage application under 35 U.S.C. 371?

The filing date determination differs between these two types of applications: For a national application under 35 U.S.C. 111(a): The filing date is generally the date when a specification is received by the USPTO, as per 37 CFR 1.53(b). For a national stage application under 35 U.S.C. 371: The filing date is the international filing…

Read More

What are the main differences between a national application filed under 35 U.S.C. 111(a) and a national stage application submitted under 35 U.S.C. 371?

The main differences between a national application filed under 35 U.S.C. 111(a) and a national stage application submitted under 35 U.S.C. 371 include: Filing Date Priority Requirements Unity of Invention Filing Fees As stated in MPEP 1896: “The differences between a national application filed under 35 U.S.C. 111(a) and a national application submitted under 35…

Read More

What are the conditions for a national application to claim the benefit of a prior international application?

For a national application to claim the benefit of a prior international application designating the United States, certain conditions must be met. MPEP 211.01(c) outlines these conditions, referencing 35 U.S.C. 365(c) and 35 U.S.C. 120: The first sentence of 35 U.S.C. 365(c) specifically provides that ‘[i]n accordance with the conditions and requirements of section 120,……

Read More